Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Aggressive Desmoid Tumor
NCT02495519Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Apr 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in aggressive fibromatosis (AF), sponsored by Yonsei University. Started Apr 2014; status: completed.
02
Drugs
03
Conditions
aggressive fibromatosis (AF)
Beyond the preview
Go deeper on NCT02495519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495519.